Weirath Nicholas A, Hurben Alexander K, Chao Christopher, Pujari Suresh S, Cheng Tao, Liu Shujun, Tretyakova Natalia Y
Department of Medicinal Chemistry and Masonic Cancer Center, University of Minnesota, 2231 6th Street SE, 2-147 CCRB, Minneapolis, Minnesota 55455, United States.
The Hormel Institute, University of Minnesota, 801 16th Avenue NE, Austin, Minnesota 55912, United States.
ACS Med Chem Lett. 2022 Apr 21;13(5):792-798. doi: 10.1021/acsmedchemlett.1c00677. eCollection 2022 May 12.
Ten eleven translocation (TET) dioxygenases 1-3 are non-heme Fe(II) and α-ketoglutarate dependent enzymes that catalyze oxidation of 5-methylcytosine (5mC) in DNA to hydroxymethyl-C, formyl-C, and carboxy-C. This typically leads to gene activation and epigenetic remodeling. Most known inhibitors of TET are α-ketoglutarate mimics that may interfere with other α-ketoglutarate dependent enzymes. Recently, a novel cytosine-based inhibitor of TET, Bobcat339, was reported to have mid-μM inhibitory activity against TET1 and TET2. The molecule is now sold as a TET inhibitor by several vendors. We independently prepared Bobcat339 in our laboratory and observed that it had minimal inhibitory activity against human TET1 and TET2 via a quantitative LC-ESI-MS/MS assay. Furthermore, the inhibitory activity of commercial Bobcat339 preparations was directly correlated with Cu(II) content. We therefore conclude that Bobcat339 alone is not capable of inhibiting TET enzymes at the reported concentrations, and that its activity is enhanced by contaminating Cu(II).
10-11易位(TET)双加氧酶1-3是依赖非血红素铁(II)和α-酮戊二酸的酶,可催化DNA中的5-甲基胞嘧啶(5mC)氧化为羟甲基胞嘧啶、甲酰基胞嘧啶和羧基胞嘧啶。这通常会导致基因激活和表观遗传重塑。大多数已知的TET抑制剂是α-酮戊二酸类似物,可能会干扰其他依赖α-酮戊二酸的酶。最近,一种新型的基于胞嘧啶的TET抑制剂Bobcat339被报道对TET1和TET2具有中微摩尔级的抑制活性。现在有几家供应商将该分子作为TET抑制剂出售。我们在实验室中独立制备了Bobcat339,并通过定量液相色谱-电喷雾串联质谱(LC-ESI-MS/MS)分析观察到它对人TET1和TET2的抑制活性极小。此外,市售Bobcat339制剂的抑制活性与铜(II)含量直接相关。因此,我们得出结论,单独的Bobcat339在报道的浓度下不能抑制TET酶,其活性因铜(II)污染而增强。